Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Feb;127(2):e359-66.
doi: 10.1542/peds.2010-1627. Epub 2011 Jan 24.

Effects of recombinant human prolactin on breast milk composition

Affiliations
Randomized Controlled Trial

Effects of recombinant human prolactin on breast milk composition

Camille E Powe et al. Pediatrics. 2011 Feb.

Abstract

Objective: The objective of this study was to determine the impact of recombinant human prolactin (r-hPRL) on the nutritional and immunologic composition of breast milk.

Methods: We conducted 2 trials of r-hPRL treatment. In the first study, mothers with documented prolactin deficiency were given r-hPRL every 12 hours in a 28-day, open-label trial. In the second study, mothers with lactation insufficiency that developed while they were pumping breast milk for their preterm infants were given r-hPRL daily in a 7-day, double-blind, placebo-controlled trial. Breast milk characteristics were compared before and during 7 days of treatment.

Results: Among subjects treated with r-hPRL (N = 11), milk volumes (73 ± 36 to 146 ± 54 mL/day; P < .001) and milk lactose levels (155 ± 15 to 184 ± 8 mmol/L; P = .01) increased, whereas milk sodium levels decreased (12.1 ± 2.0 to 8.3 ± 0.5 mmol/L; P = .02). Milk calcium levels increased in subjects treated with r-hPRL twice daily (2.8 ± 0.6 to 5.0 ± 0.9 mmol/L; P = .03). Total neutral (1.5 ± 0.3 to 2.5 ± 0.4 g/L; P = .04) and acidic (33 ± 4 to 60 ± 6 mg/L; P = .02) oligosaccharide levels increased in r-hPRL-treated subjects, whereas total daily milk immunoglobulin A secretion was unchanged.

Conclusions: r-hPRL treatment increased milk volume and induced changes in milk composition similar to those that occur during normal lactogenesis. r-hPRL also increased antimicrobially active oligosaccharide concentrations. These effects were achieved for women with both prolactin deficiency and lactation insufficiency.

Trial registration: ClinicalTrials.gov NCT00181610 NCT00181623.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Correlation between milk lactose levels and milk volume before (n = 11) (closed circles and solid line) and after (n = 11) (open circles and dashed line) treatment with r-hPRL.
FIGURE 2
FIGURE 2
Mean ± SE milk prolactin concentrations for prolactin-deficient mothers treated with r-hPRL (n = 5) (closed circles) and mothers of preterm infants treated with r-hPRL (n = 6) (closed triangles) and individual prolactin concentrations for mothers of preterm infants treated with placebo (n = 2) (open squares). Prolactin concentrations were higher on days 5 to 7, compared with baseline, for mothers treated with r-hPRL (*P < .01). Prolactin concentrations returned to baseline on day 14 for prolactin-deficient mothers treated with r-hPRL for 28 days (n = 5; **P < .001).

References

    1. Neifert MR. Prevention of breastfeeding tragedies. Pediatr Clin North Am. 2001;48(2):273–294 - PubMed
    1. Brun del Re R, del Pozo E, de Grandi P, Friesen H, Hinselmann M, Wyss H. Prolactin inhibition and suppression of puerperal lactation by a Br-ergocryptine (CB 154). A comparison with estrogen. Obstet Gynecol. 1973;41(6):884–890 - PubMed
    1. Kauppila A, Chatelain P, Kirkinen P, Kivinen S, Ruokonen A. Isolated prolactin deficiency in a woman with puerperal alactogenesis. J Clin Endocrinol Metab. 1987;64(2):309–312 - PubMed
    1. Neville MC, Allen JC, Archer PC, et al. Studies in human lactation: milk volume and nutrient composition during weaning and lactogenesis. Am J Clin Nutr. 1991;54(1):81–92 - PubMed
    1. Kulski JK, Hartmann PE. Changes in human milk composition during the initiation of lactation. Aust J Exp Biol Med Sci. 1981;59(1):101–114 - PubMed

Publication types

Associated data